v3.26.1
Financial Assets & Liabilities (Tables)
 3 Months Ended
Mar. 31, 2026
Investments, All Other Investments [Abstract]  
Financial assets and financial liabilities measured at fair value on a recurring basis
The following table presents the company’s financial assets and financial liabilities that are measured at fair value on a recurring basis at March 31, 2026 and December 31, 2025.
Fair Value
Hierarchy
Level		At March 31, 2026At December 31, 2025
($ in millions)
Assets (4)
Liabilities (5)
Assets (4)
Liabilities (5)
Cash equivalents: (1)
Time deposits, certificates of deposit and other (2)
2$3,066 N/A$7,072 N/A
Money market funds
11,934 N/A 413 N/A
Total cash equivalents$5,000 N/A$7,485 N/A
Debt securities — current (2) (3)
2964 N/A830 N/A
Debt securities — noncurrent
2,39 N/A9 N/A
Derivatives designated as hedging instruments:
Interest rate contracts21 195 2 171 
Foreign exchange contracts2738 399 545 325 
Derivatives not designated as hedging instruments:
Foreign exchange contracts211 37 12 14 
Equity contracts20 62 34 3 
Total$6,724 $693 $8,916 $513 
(1)Included within cash and cash equivalents in the Consolidated Balance Sheet.
(2)Available-for-sale debt securities with carrying values that approximate fair value.
(3)Term deposits and government securities that are reported within marketable securities in the Consolidated Balance Sheet.
(4)The gross balances of derivative assets contained within prepaid expenses and other current assets, and investments and sundry assets in the Consolidated Balance Sheet at March 31, 2026 were $568 million and $182 million, respectively, and at December 31, 2025 were $232 million and $361 million, respectively.
(5)The gross balances of derivative liabilities contained within other accrued expenses and liabilities, and other liabilities in the Consolidated Balance Sheet at March 31, 2026 were $254 million and $439 million, respectively, and at December 31, 2025 were $254 million and $259 million, respectively.
N/A – not applicable